Lataa...
Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer
Irinotecan (CPT-11) is widely used for the treatment of unresectable colorectal cancer in combination with fluoropyrimidines, such as 5-fluorouracil and S-1. Diarrhea is one of the adverse effects associated with CPT-11 and frequently reported by patients treated with CPT-11-containing regimens comb...
Tallennettuna:
| Julkaisussa: | Pharmaceuticals (Basel) |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8073045/ https://ncbi.nlm.nih.gov/pubmed/33921605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14040377 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|